AAPL322.63+7.29 (+2.31%) ▲|ABBV252.17+1.26 (+0.50%) ▲|ABT104.35-0.88 (-0.84%) ▼|ACN178.53+2.73 (+1.55%) ▲|ADBE251.73-3.13 (-1.23%) ▼|AMAT458.68-10.18 (-2.17%) ▼|AMD507.81-13.29 (-2.55%) ▼|AMGN383.61-7.66 (-1.96%) ▼|AMT173.00-2.44 (-1.39%) ▼|AMZN252.55+0.15 (+0.06%) ▲|AVGO364.08-0.30 (-0.08%) ▼|AXP321.38-0.42 (-0.13%) ▼|BA207.42+1.00 (+0.48%) ▲|BAC62.47-0.20 (-0.32%) ▼|BKNG176.11+2.68 (+1.54%) ▲|BLK1,073.53+1.50 (+0.14%) ▲|BMY64.03-0.38 (-0.59%) ▼|BNY163.10+0.59 (+0.36%) ▲|BRK-B505.82-0.91 (-0.18%) ▼|C138.16+0.36 (+0.26%) ▲|CAT806.74-8.83 (-1.08%) ▼|CL88.03+0.00 (+0.00%) ▲|CMCSA24.92+0.33 (+1.32%) ▲|COF208.53-2.33 (-1.11%) ▼|COP136.38-0.15 (-0.11%) ▼|COST902.78+0.18 (+0.02%) ▲|CRM245.57+1.41 (+0.58%) ▲|CSCO108.99-0.44 (-0.40%) ▼|CVS95.35-0.03 (-0.03%) ▼|CVX213.24-0.57 (-0.27%) ▼|DE677.60+0.39 (+0.06%) ▲|DHR202.23-2.63 (-1.28%) ▼|DIS104.86+0.68 (+0.65%) ▲|DUK119.41-1.02 (-0.85%) ▼|EMR148.62-1.73 (-1.15%) ▼|FDX312.28+3.09 (+1.00%) ▲|GD353.47+0.80 (+0.23%) ▲|GE325.22-0.20 (-0.06%) ▼|GEV934.42-16.62 (-1.75%) ▼|GILD144.40-1.25 (-0.86%) ▼|GM85.13+1.37 (+1.64%) ▲|GOOG327.56-0.82 (-0.25%) ▼|GOOGL329.97-0.68 (-0.21%) ▼|GS1,025.33-3.45 (-0.34%) ▼|HD307.15-3.30 (-1.06%) ▼|HON203.59-1.34 (-0.65%) ▼|IBM238.05-1.90 (-0.79%) ▼|INTC101.57-4.67 (-4.40%) ▼|INTU315.51+1.57 (+0.50%) ▲|ISRG359.90+6.66 (+1.88%) ▲|JNJ266.69-0.39 (-0.15%) ▼|JPM353.78-0.93 (-0.26%) ▼|KO88.40+0.85 (+0.97%) ▲|LIN461.80-4.86 (-1.04%) ▼|LLY1,128.18+3.97 (+0.35%) ▲|LMT527.14+2.68 (+0.51%) ▲|LOW196.10-2.50 (-1.26%) ▼|LRCX304.33-11.51 (-3.64%) ▼|MA565.40-2.10 (-0.37%) ▼|MCD253.33-0.15 (-0.06%) ▼|MDLZ61.99-0.43 (-0.69%) ▼|MDT91.62-0.28 (-0.30%) ▼|META651.46-2.24 (-0.34%) ▼|MMM162.11-2.30 (-1.40%) ▼|MO68.79+0.90 (+1.33%) ▲|MRK144.82-2.71 (-1.84%) ▼|MS215.00-0.35 (-0.16%) ▼|MSFT492.59+0.94 (+0.19%) ▲|MU983.74-44.03 (-4.28%) ▼|NEE82.37-0.28 (-0.34%) ▼|NFLX75.97-0.06 (-0.08%) ▼|NKE37.10-0.26 (-0.68%) ▼|NOW134.00+2.89 (+2.20%) ▲|NVDA218.44-5.23 (-2.34%) ▼|ORCL158.89-2.74 (-1.70%) ▼|PEP136.80+0.11 (+0.08%) ▲|PFE27.52-0.26 (-0.94%) ▼|PG142.30-0.34 (-0.24%) ▼|PLTR167.75-1.78 (-1.05%) ▼|PM190.44+4.73 (+2.54%) ▲|QCOM177.91+1.51 (+0.85%) ▲|RTX197.28-0.30 (-0.15%) ▼|SBUX99.90-0.14 (-0.14%) ▼|SCHW107.02+0.48 (+0.45%) ▲|SO88.63+0.28 (+0.32%) ▲|SPG206.05+1.42 (+0.69%) ▲|T25.65+0.49 (+1.95%) ▲|TMO601.57-4.12 (-0.68%) ▼|TMUS176.58-0.76 (-0.43%) ▼|TSLA366.86-0.95 (-0.26%) ▼|TXN257.18-4.41 (-1.69%) ▼|UBER69.68-1.43 (-2.00%) ▼|UNH398.24+5.17 (+1.31%) ▲|UNP287.53+2.74 (+0.96%) ▲|UPS99.38+0.16 (+0.16%) ▲|USB62.24+0.11 (+0.17%) ▲|V366.64-0.94 (-0.26%) ▼|VZ50.51+0.75 (+1.51%) ▲|WFC89.75+0.07 (+0.07%) ▲|WMT107.00+1.17 (+1.10%) ▲|XOM164.83+0.57 (+0.34%) ▲|AAPL322.63+7.29 (+2.31%) ▲|ABBV252.17+1.26 (+0.50%) ▲|ABT104.35-0.88 (-0.84%) ▼|ACN178.53+2.73 (+1.55%) ▲|ADBE251.73-3.13 (-1.23%) ▼|AMAT458.68-10.18 (-2.17%) ▼|AMD507.81-13.29 (-2.55%) ▼|AMGN383.61-7.66 (-1.96%) ▼|AMT173.00-2.44 (-1.39%) ▼|AMZN252.55+0.15 (+0.06%) ▲|AVGO364.08-0.30 (-0.08%) ▼|AXP321.38-0.42 (-0.13%) ▼|BA207.42+1.00 (+0.48%) ▲|BAC62.47-0.20 (-0.32%) ▼|BKNG176.11+2.68 (+1.54%) ▲|BLK1,073.53+1.50 (+0.14%) ▲|BMY64.03-0.38 (-0.59%) ▼|BNY163.10+0.59 (+0.36%) ▲|BRK-B505.82-0.91 (-0.18%) ▼|C138.16+0.36 (+0.26%) ▲|CAT806.74-8.83 (-1.08%) ▼|CL88.03+0.00 (+0.00%) ▲|CMCSA24.92+0.33 (+1.32%) ▲|COF208.53-2.33 (-1.11%) ▼|COP136.38-0.15 (-0.11%) ▼|COST902.78+0.18 (+0.02%) ▲|CRM245.57+1.41 (+0.58%) ▲|CSCO108.99-0.44 (-0.40%) ▼|CVS95.35-0.03 (-0.03%) ▼|CVX213.24-0.57 (-0.27%) ▼|DE677.60+0.39 (+0.06%) ▲|DHR202.23-2.63 (-1.28%) ▼|DIS104.86+0.68 (+0.65%) ▲|DUK119.41-1.02 (-0.85%) ▼|EMR148.62-1.73 (-1.15%) ▼|FDX312.28+3.09 (+1.00%) ▲|GD353.47+0.80 (+0.23%) ▲|GE325.22-0.20 (-0.06%) ▼|GEV934.42-16.62 (-1.75%) ▼|GILD144.40-1.25 (-0.86%) ▼|GM85.13+1.37 (+1.64%) ▲|GOOG327.56-0.82 (-0.25%) ▼|GOOGL329.97-0.68 (-0.21%) ▼|GS1,025.33-3.45 (-0.34%) ▼|HD307.15-3.30 (-1.06%) ▼|HON203.59-1.34 (-0.65%) ▼|IBM238.05-1.90 (-0.79%) ▼|INTC101.57-4.67 (-4.40%) ▼|INTU315.51+1.57 (+0.50%) ▲|ISRG359.90+6.66 (+1.88%) ▲|JNJ266.69-0.39 (-0.15%) ▼|JPM353.78-0.93 (-0.26%) ▼|KO88.40+0.85 (+0.97%) ▲|LIN461.80-4.86 (-1.04%) ▼|LLY1,128.18+3.97 (+0.35%) ▲|LMT527.14+2.68 (+0.51%) ▲|LOW196.10-2.50 (-1.26%) ▼|LRCX304.33-11.51 (-3.64%) ▼|MA565.40-2.10 (-0.37%) ▼|MCD253.33-0.15 (-0.06%) ▼|MDLZ61.99-0.43 (-0.69%) ▼|MDT91.62-0.28 (-0.30%) ▼|META651.46-2.24 (-0.34%) ▼|MMM162.11-2.30 (-1.40%) ▼|MO68.79+0.90 (+1.33%) ▲|MRK144.82-2.71 (-1.84%) ▼|MS215.00-0.35 (-0.16%) ▼|MSFT492.59+0.94 (+0.19%) ▲|MU983.74-44.03 (-4.28%) ▼|NEE82.37-0.28 (-0.34%) ▼|NFLX75.97-0.06 (-0.08%) ▼|NKE37.10-0.26 (-0.68%) ▼|NOW134.00+2.89 (+2.20%) ▲|NVDA218.44-5.23 (-2.34%) ▼|ORCL158.89-2.74 (-1.70%) ▼|PEP136.80+0.11 (+0.08%) ▲|PFE27.52-0.26 (-0.94%) ▼|PG142.30-0.34 (-0.24%) ▼|PLTR167.75-1.78 (-1.05%) ▼|PM190.44+4.73 (+2.54%) ▲|QCOM177.91+1.51 (+0.85%) ▲|RTX197.28-0.30 (-0.15%) ▼|SBUX99.90-0.14 (-0.14%) ▼|SCHW107.02+0.48 (+0.45%) ▲|SO88.63+0.28 (+0.32%) ▲|SPG206.05+1.42 (+0.69%) ▲|T25.65+0.49 (+1.95%) ▲|TMO601.57-4.12 (-0.68%) ▼|TMUS176.58-0.76 (-0.43%) ▼|TSLA366.86-0.95 (-0.26%) ▼|TXN257.18-4.41 (-1.69%) ▼|UBER69.68-1.43 (-2.00%) ▼|UNH398.24+5.17 (+1.31%) ▲|UNP287.53+2.74 (+0.96%) ▲|UPS99.38+0.16 (+0.16%) ▲|USB62.24+0.11 (+0.17%) ▲|V366.64-0.94 (-0.26%) ▼|VZ50.51+0.75 (+1.51%) ▲|WFC89.75+0.07 (+0.07%) ▲|WMT107.00+1.17 (+1.10%) ▲|XOM164.83+0.57 (+0.34%) ▲|
27.5 C
New York
Thursday, September 10, 2026

Tag: rate

Greenbacker sells 51 MW distributed solar portfolio, advancing strategic focus on scaled clean energy projects

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Greenbacker, an energy transition-focused investment manager and independent power producer, today announced the sale of a 51.2 MW portfolio of 64 operating solar assets to CleanCapital, a leading independent power producer specializing in distributed clean energy. This transaction reflects Greenbacker’s broader strategy to optimize its project fleet for long-term growth with selective sales of non-core assets and a sharpened focus on larger-scale clean energy projects. The sale also supports greater operational efficiency, allowing the firm to reallocate resources toward the construction of higher-impact projects across its pre-operating portfolio.

Boyd Group Services Inc. Reports Second Quarter 2025 Results

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ - Profitability initiatives drive margin expansion; Location count surpasses 1,000 early...

China Automotive Systems Reports Income From Operations Increased by 20.2% in the Second Quarter of 2025

WUHAN, China, Aug. 13, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in...

Telitacicept Meets Primary Endpoint in Phase III Trial for Primary Sjögren’s Syndrome in China

YANTAI, China, Aug. 13, 2025 /PRNewswire/ -- On August 13th, Remegen (688331.SH/09995.HK) announced that its global first-in-class BLyS (BAFF)/APRIL dual-target fusion protein drug, Telitacicept, met...

Performance Brokerage Services Advises on the Sale of Covina Hills Chevrolet in Covina, California

Performance Brokerage Services, the leader in dealership buy-sell activity, announces the sale of Covina Hills Chevrolet in Covina, California from Jim Ross to Braeden...

[Latest] Global Canine Orthopedics Market Size/Share Worth USD 945.2 Million by 2034 at a 8.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Canine Orthopedics Market size & share revenue was valued at approximately USD 420.2 Million in 2024 and is expected to reach USD 454.6 Million in 2025 and is expected to reach around USD 945.2 Million by 2034, at a CAGR of 8.6% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are B. Braun Melsungen AG, Movora (Vimian Group AB), Integra LifeSciences Corporation, DePuy Synthes (Johnson & Johnson), AmerisourceBergen Corporation, STERIS, Arthrex Inc. (Arthrex Vet Systems), Orthomed (UK) Ltd, Veterinary Instrumentation, BioMedtrix LLC, Fusion Implants Limited, Narang Medical Limited, Zoetis Inc., IMEX Veterinary Inc., Everost Inc and others.
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Canine Orthopedics Market size & share revenue was valued at approximately USD 420.2 Million in 2024 and is expected to reach USD 454.6 Million in 2025 and is expected to reach around USD 945.2 Million by 2034, at a CAGR of 8.6% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are B. Braun Melsungen AG, Movora (Vimian Group AB), Integra LifeSciences Corporation, DePuy Synthes (Johnson & Johnson), AmerisourceBergen Corporation, STERIS, Arthrex Inc. (Arthrex Vet Systems), Orthomed (UK) Ltd, Veterinary Instrumentation, BioMedtrix LLC, Fusion Implants Limited, Narang Medical Limited, Zoetis Inc., IMEX Veterinary Inc., Everost Inc and others.

[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach around USD 252.93 Billion by 2034, at a CAGR of 17.32% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc., Precision Biologics, Danaher Corporation (Cepheid Inc.), GE HealthCare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., Biogen, QIAGEN, Genentech Inc., 23andMe Inc., Asuragen Inc and others.
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach around USD 252.93 Billion by 2034, at a CAGR of 17.32% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc., Precision Biologics, Danaher Corporation (Cepheid Inc.), GE HealthCare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., Biogen, QIAGEN, Genentech Inc., 23andMe Inc., Asuragen Inc and others.

Aviation Cyber Security Market Set to Grow to USD 15.77 Billion by 2032 | Coherent Market Insights

Burlingame, CA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Global Aviation Cyber Security Market is estimated to be valued at USD 10.07 Bn in 2025 and is expected to reach USD 15.77 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. The global aviation cybersecurity market is steadily expanding, fueled by the increasing digitization of aviation systems and the escalating threat of advanced cyberattacks aimed at airlines, airports, and aircraft systems. As the industry becomes more dependent on connected technologies, cloud platforms, and software applications for flight operations and passenger services, the need for strong cybersecurity measures throughout the aviation ecosystem has become more critical than ever.

Vietnam Secures First-Ever Export Order for 5,000 Unmanned Cargo Aircraft to a Hi-Tech Nation

SEOUL, South Korea, Aug. 12, 2025 (GLOBE NEWSWIRE) -- On August 12, 2025, a historic milestone was marked in the nation’s technology sector as Vietnam received its first order to export 5,000 unmanned cargo airplanes to a top-tier global technology powerhouse like South Korea.

Cavvy Releases Q2 2025 Financial and Operating Results

Third Party Processing Growth and Strong Hedging Gain Bolsters Cash Flow, Drives Debt Reduction
Third Party Processing Growth and Strong Hedging Gain Bolsters Cash Flow, Drives Debt Reduction

TWFG Announces Second Quarter 2025 Results

– Total Revenues increased 13.8% for the quarter over the prior year period to $60.3 million
Total Written Premium increased 14.4% for the quarter over the prior year period to $450.3 million –
– Organic Revenue Growth Rate* of 10.6% for the quarter –
– Net income of $9.0 million for the quarter
– Adjusted EBITDA* increased 40.7% for the quarter over the prior year period to $15.1 million –

Prairie Provident Announces Second Quarter 2025 Results

CALGARY, Alberta, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. ("Prairie Provident" or the "Company") (TSX:PPR) announces its financial and operating results for the second quarter of 2025. The Company’s interim financial statements for the three and six months ended June 30, 2025 and related Management’s Discussion and Analysis (“MD&A”) are available on our website at www.ppr.ca and filed on SEDAR+ at www.sedarplus.ca.

Simon Property Group Sells $1.5 Billion of Senior Notes

INDIANAPOLIS, Aug. 12, 2025 /PRNewswire/ -- Simon®, a real estate investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRate